Propel Bio Management LLC 13D and 13G filings for Eiger BioPharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-02 9:54 pm Purchase |
2023-11-02 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Propel Bio Management LLC | 179,174 12.130% |
9,275 (+5.46%) |
Filing |
| 2023-10-20 4:29 pm Purchase |
2023-10-18 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Propel Bio Management LLC | 169,900 11.510% |
9,102 (+5.66%) |
Filing |
| 2023-09-28 4:54 pm Purchase |
2023-09-14 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
Propel Bio Management LLC | 160,798 10.900% |
81,059 (+101.66%) |
Filing |
| 2023-08-15 06:00 am Purchase |
2023-08-02 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
Propel Bio Management LLC | 79,739 5.400% |
79,739 (New Position) |
Filing |